HPV (Human papillomavirus), a DNA virus is one of the most commonly sexually transmitted infection which is very common in sexually active men and women. Approximately 120 types of HPV have been indentified and among these over 30 to 40 types of HPV are transmitted through sexual contact infecting the genital region. HPV virus leads to development of cervical cancer, genital warts and other cancers of penis, vagina, throat and others. Cervical cancer is one of the most common types of cancer detected in females worldwide. It is estimated that the approximately at any point of time 42.5 percent women are diagnosed with HPV infection and whereas less than 7 percent adults are diagnosed with oral HPV infection. According to the National Cancer Institute in 2011 number of deaths of women rose to 2.4 per 10,000 women due to cervix cancer. Additionally, by the end of 2014 in the U.S. number of cases diagnosed with cervical cancers is expected to reach 12,360. Thus, regular screening and vaccines are recommended for the prevention and spread of HPV.

Browse Full Report : http://www.transparencymarketresearch.com/cytology-hpv-testing-market.html

Global cytology and HPV testing market is being identified as one of the rapidly evolving market in the field of molecular diagnostics. Rising incidences of cervical cancers and increasing awareness about preventive testing are some of the factors expected to drive the growth of this market. Cytological screening which refers to microscopic examination of cells (function, structure and morphology) has noticeably reduced the incidence of cervical cancers. Currently, HPV tests and Pap test are recommended for cervical cancer screening. In Europe, cervical cancers account for almost 57,000 of the incidents cases and 25,000 deaths annually. Hence, in many of the European countries HPV vaccinations are introduced for women for prevention of HPV infection. Cervarix (GlaxoSmith Kline) and Gardasil (Merck & Co.) are two vaccines which are commercially available for the prevention of HPV infection.

Apart, from vaccination and primary screening some of the treatment options are also available for the treatment of genital warts and precancerous lesions. Such treatment option includes cryosurgery, surgical conization, loop electrosurgical excision procedure (LEEP) and laser vaporization conization. Similarly, topical chemicals and drugs are also available for the treatment of precancerous lesions caused by HPV (vaginal, penile, vulvar and lesions). Additionally, in order to reduce the incidence of infection several companies are also striving to launch innovative and differential products into this market. Recently, Roche Diagnostics launched a test (cobas HPV test) in the U.S.

Geographically, North America accounts for the largest share of the global cytology and HPV testing market. Rising incidences of women suffering from cervical cancers each year and favorable government measures that are focused towards proper screening, immunization programs and diagnosing are some of the factors held responsible for leadership position of this region. However, in the near future Asian region and Latin American region is expected to show healthy growth in the near future due to the fact that 80% of the cases diagnosed for cervical cancers globally are reported from developing countries with high mortality rates. The majority of the deaths due to cervical cancers in these regions are reported due to poor healthcare infrastructure and low awareness level.

Request A Sample Of This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2216

Major market players operating in cytology and HPV testing market includes Abbott Laboratories, CytoCore, Inc., Becton and Dickinson, Hologic Inc., Third Wave Technologies, Roche Diagnostics, Merck & Co., Qiagen, Inc., DaAn Gene Co., Ventana Medical Systems and other significant players.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
• North America
• Asia Pacific
• Europe
• Rest of the World
This report provides comprehensive analysis of
• Market growth drivers
• Factors limiting market growth
• Current market trends
• Market structure
• Market projections for upcoming years


About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact us:
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email:Â [email protected]
Website: http://www.transparencymarketresearch.com/